`
`
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF OHIO
`EASTERN DIVISION
`
`BAYMARK HEALTH SERVICES OF OHIO, INC.,
`1720 Lakepointe Drive, Suite 117
`Lewisville, TX 75057,
`
`
`
`MKB HOLDINGS, LLC,
`3659 Green Road, Suite 214
`Cleveland, OH 44122,
`
`
`
`
`
`CITY OF PARMA HEIGHTS, OHIO,
`6281 Pearl Road
`Parma Heights, OH 44130,
`
`
`
`CITY OF PARMA HEIGHTS PLANNING
`COMMISSION,
`6281 Pearl Road
`Parma Heights, OH 44130,
`
`
`
`DENNIS PATTEN, in his official capacity as
`CITY OF PARMA HEIGHTS DIRECTOR OF
`PUBLIC SERVICE,
`6281 Pearl Road
`Parma Heights, OH 44130,
`
`
`
`
`
`Civil Action No. 1:20-cv-2754
`
`
`Judge:
`
`
`Magistrate Judge:
`
`
`
`JURY DEMAND ENDORSED
`HEREON
`
`
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`) )
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`
`
`and
`
`Plaintiffs,
`
`v.
`
`
`
`
`
`
`
`and
`
`and
`
`Defendants.
`
`COMPLAINT
`
`Plaintiffs BayMark Health Services of Ohio, Inc. (“BayMark”) and MKB Holdings,
`
`LLC (together, “Plaintiffs”), for their Complaint against Defendants City of Parma Heights,
`
`
`
`1
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 2 of 29. PageID #: 2
`
`
`
`Ohio (the “City”), the City of Parma Heights Planning Commission (the “Planning
`
`Commission”), and Dennis Patten in his official capacity as the City’s Director of Public
`
`Service (the “Director”) (collectively, “Defendants” or “Parma Heights”) aver and allege:
`
`I.
`
`INTRODUCTION
`
`1.
`
`Nearly every American has experienced the impact of the opioid crisis. Its
`
`effects have had a devastating impact across Ohio, recognized as “ground-zero for opioid
`
`overdose deaths” in the United States.1 Opioid Use Disorder (“OUD”) exists in nearly
`
`every Ohio community, particularly in Cuyahoga County and Parma Heights.
`
`2.
`
`The number of overdose deaths in Cuyahoga County surged in 2020 and is
`
`on pace to be the highest number of such deaths in three years.2 Heroin, fentanyl, and
`
`other opioids have been, and continue to be, the leading cause of overdose deaths in
`
`Cuyahoga County.3
`
`3.
`
`In response to the significant unmet need for OUD services in Parma
`
`Heights and its surrounding area, BayMark has sought to open an opioid treatment office
`
`(also known as a methadone treatment office) in Parma Heights that will provide
`
`medication assisted treatments primarily utilizing methadone and buprenorphine, along
`
`with counseling and recovery services, to provide comprehensive, evidence-based
`
`
`1 Courtney Astolfi, Report: Ohio Ground-Zero for Opioid Overdose Deaths, THE PLAIN DEALER,
`(Nov. 30, 2016), https://www.cleveland.com/metro/2016/11/report_ohio_ground-zero_for_
`op.html (“Ohio saw more opioid overdose deaths than anywhere else in the nation”).
`
`2 Evan MacDonald, Cuyahoga County Sees 19 Drug Overdose Deaths in a Week, on Pace for
`Highest Total in Three Years, THE PLAIN DEALER, (Oct. 13, 2020), https://www.cleveland.com
`/metro/2020/10/cuyahoga-county-sees-19-drug-overdose-deaths-in-a-week-on-pace-for-highest
`-total-in-three-years.html.
`
`3 Dr. Thomas P. Gilson, Cuyahoga County Medical Examiner’s Office Heroin/Fentanyl/Cocaine
`Related Deaths in Cuyahoga County, (Oct. 9, 2020) http://medicalexaminer.cuyahogacounty.
`us/pdf_medicalexaminer/en-US/HeroinFentanylReports/SEP2020-HeroinFentanylReport.pdf.
`
`
`
`2
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 3 of 29. PageID #: 3
`
`
`
`treatment for individuals with OUD.
`
`4. Methadone is prescribed to reduce or eliminate chronic opioid addiction
`
`while the client is provided a comprehensive range of treatment. Methadone is a long-
`
`acting synthetic narcotic analgesic that is administered in sustained, stable, medically
`
`determined dosage levels for periods in excess of 21 days. Among other things,
`
`methadone blocks the opiate receptor in the brain. This means that if someone on a
`
`methadone treatment were to also use an opiate, the individual will not typically feel a
`
`“high” from the opiate. In short, the methadone stabilizes someone suffering from OUD
`
`by providing a “maintenance dose” of opioids, allowing the individual to avoid
`
`withdrawal symptoms and pursue a healthy lifestyle without opioid cravings leading to
`
`relapse.
`
`5.
`
`During the course of the methadone treatments, clients suffering from OUD
`
`also receive a range of other outpatient services. These services habilitate and rehabilitate
`
`clients with OUD to a basic level of social, life, work, and health capabilities that help
`
`them become productive, independent members of society. Services include replacement
`
`therapy, evaluation of medical, employment, alcohol, criminal, and psychological
`
`problems, screening for diseases that are disproportionately represented in the opioid-
`
`abusing population, monitoring for illicit drug use, counseling by addiction counselors
`
`that are evaluated through ongoing supervision, and professional medical, social work,
`
`and mental health services either on-site or by referral.
`
`6.
`
`Unfortunately for those suffering from OUD in and around Parma Heights,
`
`the City has arbitrarily and unlawfully prevented BayMark from providing these much-
`
`needed services.
`
`
`
`3
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 4 of 29. PageID #: 4
`
`
`
`7.
`
`The City has continuously – over the course of years – refused to issue a
`
`final decision on BayMark’s pending zoning applications. Without any legitimate basis,
`
`the City has arbitrarily and capriciously refused to recognize that BayMark’s opioid
`
`treatment office is a “commercial business,” an expressly permitted use of BayMark’s
`
`property. Likewise, the City has arbitrarily and capriciously refused to approve
`
`BayMark’s site plan, even though it meets all of the requirements set forth in the City’s
`
`Zoning Code. It is now clear that while the City is refusing to act upon BayMark’s
`
`pending applications and that the City is going to impose new zoning restrictions on use
`
`of the property and prohibit BayMark from operating an opioid treatment office on the
`
`property.
`
`8.
`
`Rather than objectively applying its Zoning Code to approve BayMark’s
`
`operation of an opioid treatment office, the City has discriminated against and is
`
`continuing to discriminate against BayMark based on unsubstantiated fears and stigma
`
`against BayMark and its clients’ OUD disabilities.
`
`9.
`
`The City’s arbitrary refusal to permit BayMark to open its opioid treatment
`
`office has led to overdose deaths that could have been prevented. Meanwhile, BayMark
`
`has lost significant sums during the City’s arbitrary delays. BayMark therefore seeks
`
`injunctive, monetary, and declaratory relief for the City’s violation of the Americans with
`
`Disabilities Act, the Rehabilitation Act, the United States and Ohio Constitutions, and the
`
`City’s own Zoning Code.
`
`II. JURISDICTION AND VENUE
`
`10. This action arises under the United States Constitution, the Ohio
`
`Constitution, and laws of the United States.
`
`
`
`4
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 5 of 29. PageID #: 5
`
`
`
`11.
`
`Jurisdiction is conferred on this Court pursuant to 28 U.S.C. §§ 1331,
`
`1343(a), 1367, and 2201.
`
`12. Venue in this Court is proper under 28 U.S.C. § 1391(b) as this is the judicial
`
`district in which a substantial part of the events or omissions giving rise to the claims
`
`occurred.
`
`13. Additionally, further recourse to state procedures would be futile, and/or a
`
`final decision is not required by existing law.
`
`III. PARTIES
`
`14. BayMark is a corporation organized under the laws of the State of Ohio with
`
`its principal place of business in Lewisville, Texas. BayMark has leased a portion of the
`
`property located at 6700 Pearl Road in the City of Parma Heights, Ohio (the “Property”)
`
`for purposes of operating an opioid treatment office. BayMark sues on behalf of itself
`
`and on account of injuries it has suffered and will continue to suffer due to its association
`
`with persons with disabilities.
`
`15. MKB Holdings, LLC (“MKB”) is a limited liability company organized
`
`under the laws of the State of Ohio, with its principal place of business in Cleveland,
`
`Ohio. MKB purchased the Property in 2014 and subsequently leased a portion of the
`
`Property to BayMark.
`
`16.
`
`The City is a chartered municipal corporation and body politic operating under
`
`the laws of the State of Ohio and is situated within Cuyahoga County, Ohio. Upon
`
`information and belief, the City receives and distributes money from the federal government
`
`for its programs and activities.
`
`17. Dennis Patten is the current Director of Public Service of the City of Parma
`
`
`
`5
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 6 of 29. PageID #: 6
`
`
`
`Heights and is named in his official capacity.
`
`18.
`
`The City acts by and through various commissions and public officials
`
`including the Planning Commission and the Director.
`
`IV. FACTS COMMON TO ALL CLAIMS
`
`A. BayMark Is the Largest Opioid Treatment Program Provider in North America.
`
`19.
`
`Previous narcotic addiction, including OUD, is a disability with severe
`
`medical, emotional, and societal consequences. Persons receiving medically supervised
`
`methadone treatment are not capable of performing major life activities without the
`
`assistance and support provided by methadone treatment programs or other approved
`
`treatment modalities.
`
`20.
`
`Society incorrectly views recovering narcotic addicts, including persons
`
`suffering from OUD, as damaged individuals, incapable of leading ordinary, productive
`
`lives. Society stigmatizes previous illegal drug users and recovering drug addicts. Many
`
`people and institutions retain prejudices against former illegal drug users, including
`
`against individuals suffering from OUD.
`
`21. BayMark provides counseling and recovery services to individuals
`
`suffering from OUD. BayMark, including its affiliates, has operated in this capacity for
`
`over forty years and is the largest opioid treatment program provider in North America.
`
`BayMark and its affiliates currently operate and/or support 274 locations throughout the
`
`United States and Canada, including offices throughout Ohio. BayMark has a reputation
`
`for treating individuals with OUD, treating more than 57,000 individuals each day across
`
`its locations.
`
`22. BayMark’s treatment offices are regulated by the federal Substance Abuse
`
`and Mental Health Services Administration (“SAMHSA”) and the federal Drug
`
`
`
`6
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 7 of 29. PageID #: 7
`
`
`
`Enforcement Agency (“DEA”). BayMark’s opioid treatment offices are licensed by the
`
`State of Ohio, certified by SAMSHA, and registered with the DEA.
`
`23. BayMark’s opioid treatment programs are operated through local offices
`
`that target chronic opioid users who have failed to respond to other types of treatment.
`
`BayMark screens each new client to ensure that he or she has a history of opiate or
`
`narcotic addiction. BayMark’s clients’ addictions impair their lives in numerous ways, such
`
`as interfering with their employability, parenting, regular life functions, social interactions
`
`with others, taking care of themselves, and ability to stay out of jail.
`
`24. BayMark utilizes a multi-disciplinary approach to treating clients with
`
`OUD, addressing the physical and psychological aspects of their addiction through
`
`medication assisted treatments utilizing drugs such as methadone, buprenorphine, and
`
`vivitrol. BayMark also provides health assessments, individual and group counseling,
`
`addiction education and relapse prevention, mental health services, case management, and
`
`referrals to community resources, all on an outpatient basis at its treatment offices.
`
`BayMark’s treatment offices are for-profit, commercial businesses.
`
`25. BayMark treats every client under the supervision of licensed physicians
`
`and licensed nurse practitioners; methadone is administered by licensed nursing staff.
`
`Each office has a physician medical director.
`
`26.
`
`Some clients pay for methadone treatment out of pocket, some are covered
`
`by Medicaid, some by other public funding, and some by insurance.
`
`27. Unfortunately, there is not a magic cure for OUD. Individuals with OUD
`
`are susceptible to instances of relapse. It can therefore take years of effective treatment
`
`to cure someone with OUD.
`
`
`
`7
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 8 of 29. PageID #: 8
`
`
`
`28. There is a significant number of individuals who live in and around Parma
`
`Heights suffering from OUD. There are only a couple of public offices providing
`
`methadone maintenance treatment in Cuyahoga County, which are located in downtown
`
`Cleveland. There currently exists an unmet need for opioid treatment programs offered by
`
`BayMark in and around Parma Heights.
`
`B. BayMark Leases the Property to Meet the Needs of an Underserved Community.
`
`29. On or about September 29, 2017, BayMark entered into a lease agreement
`
`(the “Lease”) with MKB. The Lease is for seventeen (17) years, whereby MKB agreed
`
`to lease the Property to BayMark for the operation of an opioid treatment office.
`
`30. The Property is located on the north side of Pearl Road near the intersection
`
`with West 130th Street. The Property is approximately 80 feet wide by 150 feet deep and
`
`is improved with a commercial building of approximately 6,000 gross square feet that has
`
`sat vacant for approximately 8 years and continues to sit vacant.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`31. The Property is located in the City’s Class “C” Commercial Zoning District.
`
`32. The uses permitted in the Class “C” Commercial Zoning District include
`
`
`
`8
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 9 of 29. PageID #: 9
`
`
`
`any “commercial business not injurious to adjacent premises or its occupants thereof by
`
`reason of the emission of dust, fumes, smoke, odor, noise, vibration or danger to life,
`
`property, safety or health.” Parma Heights Zoning Code (“Zoning Code”) §1181.01(d)
`
`(emphasis added), a true and accurate copy of relevant portions of the Zoning Code are
`
`attached as Exhibit A.
`
`33. BayMark’s opioid treatment office is a commercial business that will emit
`
`no dust fumes, smoke, odor, noise, vibration or danger to life property, safety, or health.
`
`34. There are numerous medical offices on similarly situated properties on Pearl
`
`Road and on West 130th within the City’s Class “C” Commercial Zoning District.
`
`35.
`
`It is therefore beyond dispute that the City’s Zoning Code expressly permits
`
`the use of the Property for an opioid treatment office.
`
`C. BayMark Submits Its Proposed Site Plan to the City.
`
`36. On or about October 13, 2017, a change of use application (the “Change of
`
`Use Application”) and a preliminary site plan for BayMark’s proposed parking lot were
`
`filed with the Planning Commission.
`
`37. On or about October 19, 2017, the City responded that the Director needed
`
`to know “the type of business that will be going into that location so we can determine if
`
`there will be sufficient parking” and further advised: “A letter to the Planning
`
`Commission explaining the nature of the business and [a] business plan would be
`
`sufficient.”
`
`38. A few days later, the City Engineer provided initial comments on the
`
`preliminary site plan. BayMark submitted two alternative preliminary site plans to the
`
`City in response, one with 25 parking spaces and one with 30 parking spaces.
`
`39. On or about November 20, 2017, the City Engineer completed a second
`
`
`
`9
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 10 of 29. PageID #: 10
`
`
`
`“preliminary review” of the two alternative preliminary site plans. The City Engineer
`
`noted that the preliminary site plan would have to address certain layout issues including:
`
` adding a landscape area near an abutting property because he contended it
`
`was a residential property (the abutting property was actually a commercial
`
`property);
`
` adding a loading area;
`
` depicting parking spaces that were 9’ X 20’ in size; and
`
`
`
`illustrating the Property’s dimensions, grading, and utilities on the plan.
`
`The City Engineer also opined, in error, that more than 25 parking spaces would be
`
`required.
`
`D. BayMark Revises the Site Plan to Satisfy the Zoning Code Requirements and
`Address the City Engineer’s Comments.
`
`40. The Zoning Code only requires 24 parking spaces for BayMark’s opioid
`
`treatment office based on the floor area of the building on the Property.
`
`41. Medical offices need only provide “5 [parking] spaces per 1,000 sq. ft.” of
`
`“floor area.” Zoning Code §1187.06.
`
`42.
`
`“Floor area” is defined as:
`
`the total usable floor area of all the floors excluding areas devoted to
`mechanical equipment, stairways, elevators, restrooms, employees’
`lounges, public hallways and areas used for the storage and/or packaging of
`merchandise and supplies, provided, however, that such excluded area does
`not exceed twenty percent.
`
`Zoning Code §1187.05(b) (emphasis added).
`
`43. The exterior dimensions of the BayMark’s building on the Property is 6,000
`
`gross square feet. After applying the 20% exclusion for areas devoted to mechanical
`
`equipment, restrooms, employee lounge(s), public hallways and areas used for the
`
`
`
`10
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 11 of 29. PageID #: 11
`
`
`
`storage, there is at most, 4,800 square feet of “floor area.” Consequently, only 24 parking
`
`spaces are required by the Zoning Code.
`
`44. Accordingly, BayMark, responded to the City on or about December 20,
`
`2017, explaining the nature of BayMark’s business, that 25 parking spaces were
`
`sufficient, and that the abutting parcel was not zoned residential. A true and accurate
`
`copy of the December 20, 2017 letter is attached as Exhibit B.
`
`E. The City Arbitrarily Delays Consideration of BayMark’s Application.
`
`45. On or about January 16, 2018, the Director notified BayMark that it was
`
`required to provide responses to eight prompts, including among other things, providing
`
`yet another explanation of how BayMark proposed to use the Property. Additionally, the
`
`Director required BayMark provide a detailed floor plan of the building’s interior
`
`prepared by a state certified design professional – even though the Commission was only
`
`reviewing the preliminary site plan for exterior parking lot.
`
`46. BayMark responded on or about January 26, 2018, addressing each of the
`
`Director’s prompts and enclosing a preliminary site plan. BayMark noted that the
`
`requested interior floor plan prepared by a state certified design professional was not
`
`necessary and not required under either Chapter 1133 or 1187 of the Zoning Code.
`
`BayMark explained that interior plans would eventually be prepared in connection with
`
`a building permit for changes to the building’s interior, but such plans were not necessary
`
`for approval of the site plan for the parking lot. BayMark included a revised preliminary
`
`site plan that complied with all applicable requirements in the Zoning Code.
`
`47. Between February 2018 and May 2018, BayMark responded to still more
`
`letters, questions, and requests for information from the City. In turn, the City continued
`
`to demand irrelevant information from BayMark, while simultaneously failing to provide
`
`
`
`11
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 12 of 29. PageID #: 12
`
`
`
`specific guidance as to what would be required of BayMark for the approval of its Change
`
`of Use Application and preliminary site plan.
`
`48. On or about May 18, 2018, the City agreed that BayMark’s preliminary site
`
`plan dated April 27, 2018 was “in general conformance with the City of Parma Heights
`
`requirements....” The City reiterated that it would nonetheless require BayMark to submit
`
`an interior floor plan prepared by a state certified design professional and requested the
`
`site plan also depict the location of drainage patterns; any new retaining wall locations, if
`
`any; approximate limits of parking expansion; and the location of new storm sewer
`
`infrastructure, if any.
`
`49. BayMark revised the preliminary site plan to add each of the elements
`
`requested by the City, and paid to have a state certified architect prepare an interior floor
`
`plan to demonstrate the preliminary site plan’s compliance with the Zoning Code’s
`
`parking requirements. A true and accurate copy of the floor plan and information showing
`
`the square footage of excluded areas is attached as Exhibit C.
`
`50. BayMark submitted its site plan application (“Site Plan Application”) and
`
`floor plan on or about May 31, 2018. True and accurate copies of the Site Plan
`
`Application and Change of Use Application are attached as Exhibit D (together, the Site
`
`Plan Application and Change of Use Application are the “Applications”).
`
`F. The Planning Commission Randomly and Arbitrarily Refuses to Act Upon or
`Approve BayMark’s Applications.
`
`51. On July 2, 2018, the Planning Commission heard BayMark’s Applications.
`
`During the meeting, representatives from BayMark presented 13 exhibits supporting
`
`approval of its two narrow Applications. BayMark also answered numerous questions
`
`regarding various business, staffing, financial, and treatment issues.
`
`
`
`12
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 13 of 29. PageID #: 13
`
`
`
`52. During the July 2 public hearing, the Commission read letters from “the
`
`community” that opposed BayMark’s use based on unfounded fears and stigma against
`
`BayMark’s clients suffering from OUD.
`
`53. Despite nine months of communications between the City and BayMark,
`
`and the information provided during the meeting concerning the narrow issues before the
`
`Commission, the Planning Commission nonetheless advised that it was at the very
`
`beginning of an “information gathering” phase. Rather than voting on the Change of Use
`
`Application – resolving whether BayMark’s opioid treatment office is a commercial
`
`business – or the Site Plan Application – approval of the parking lot’s layout – the
`
`Planning Commission tabled both Applications “to gather further information regarding
`
`this business.”4
`
`54. Despite knowing the nature of BayMark’s business that would be used on
`
`the Property, the City wrote BayMark in a letter dated July 16, 2018, to request even more
`
`information, none of which was necessary to issue a decision on the two narrow issues
`
`before the Planning Commission and was not required by the Zoning Code. The letter
`
`stated:
`
`The Planning Commission is requesting the following items to aid in its
`understanding of the new facility that BayMark is proposing.
`
`1.
`
`2.
`
`The name and addresses of BayMark’s eleven similar facilities in
`development throughout Ohio, as well as the name and address of
`the existing facility that BayMark referred to during its Planning
`presentation.
`
`A copy of the lease for the property that was referenced in the
`presentation.
`
`3.
`
`A copy of the study referenced during the presentation that led
`
`
`4 A copy of the Planning Commission’s July 2, 2018 meeting minutes are available on the City’s
`website at: http://parmaheightsoh.gov/en-US/SYN//84593/EventTemplate.aspx.
`
`
`
`13
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 14 of 29. PageID #: 14
`
`
`
`BayMark to this location.
`
`4.
`
`5.
`
`A breakdown of the payroll amounts at the proposed facility that
`were cited during the presentation.
`
`An estimate of the net profit tax chargeable to the proposed
`facility.
`
`Emphasis added. The Commission’s questions, on their face, establish that the Planning
`
`Commission knew and understood that BayMark’s opioid treatment office is a permitted
`
`“commercial business.”
`
`55. Through a letter dated July 20, 2018, BayMark provided its responses to
`
`each of the Planning Commission’s requests and requested its Applications be included
`
`on the Commission’s August 6, 2018 meeting agenda.
`
`56. The Commission did not place the Applications on its agenda. Instead, on
`
`or about August 17, 2018, the Planning Commission sent BayMark a list of 41 additional
`
`questions for which the Commission purported to need answers “to aid in its
`
`understanding of the new facility that BayMark is proposing.” A true and accurate copy
`
`of the August 17, 2018 letter is attached as Exhibit E.
`
`57. As set forth in the August 17, 2018 letter, the questions directed to BayMark
`
`were irrelevant, motivated by the Planning Commission’s continued discrimination and
`
`bias against persons with OUD, and well beyond the scope of the established procedures
`
`for considering a change of use application or an exterior, parking lot site plan. By way
`
`of example only, the Planning Commission purported to need to know:
`
`a. The criteria “used for determining the facility proposed by BayMark
`Health Services should be located in Parma Hts. . . . Please provide
`all available data utilized such as paramedic overdose run reports,
`emergency room reports from communities and hospitals within a 5
`mile radius of the facility proposed by Baymark Health Services.”
`
`b. “Of the facilities operated by Baymark how many have been subject
`
`
`
`14
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 15 of 29. PageID #: 15
`
`
`
`to criminal activity such as break ins of the facility?”
`
`c. “Of the facilities operated by Baymark how many have been subject
`to criminal activities such other than [sic] break ins, such as petty
`theft, etc., on the grounds of the facility?”
`
`d. “Have any of the facilities operated by Baymark ever been shut down
`by the local community due to being an attractive nuisance? If yes,
`please provide details including the locations and dates.”
`
`e. “How many drug dependency treatment facilities exist within a ten
`(10) mile radius of the proposed location in Parma Hts.? How many
`of these facilities are operated in conjunction with the major local
`healthcare providers . . . How many of these facilities are operated
`by independent private licensed medical professionals, charities,
`state/local agencies, etc. . . . Please provide a map of the locations of
`all the drug dependency treatment facilities within ten (10) miles of
`the proposed facility.”
`
`58. Upon information and belief, the Planning Commission has not required
`
`other similarly situated applicants to undergo such an “information gathering” phase
`
`before the Planning Commission would act upon their applications.
`
`59. Upon information and belief, the Planning Commission has not required
`
`similarly situated applicants to answer questions of this extent and nature in order to
`
`obtain a decision on a change of use application or a site plan application.
`
`60. On or about September 14, 2018, BayMark provided the Planning
`
`Commission with a written response providing answers to the Commission’s multitude
`
`of requests. BayMark again requested the Planning Commission to consider and vote on
`
`its Applications. A true and accurate copy of the September 14, 2018 letter is attached as
`
`Exhibit F.
`
`61. On or about October 23, 2018, the City arbitrarily contrived a new
`
`argument, claiming for the first time that BayMark’s use was a “clinic” instead of a
`
`
`
`15
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 16 of 29. PageID #: 16
`
`
`
`“medical office” for purposes of calculating the requisite number of parking spaces.5
`
`However, the Zoning Code does not define either a “clinic” or a “medical office.” The
`
`City did not provide BayMark with any rationale or explanation for its new position. As
`
`a result of this new interpretation, the City claimed that BayMark would need to provide
`
`additional parking spaces over-and-above the number of spaces required for a medical
`
`office.
`
`62. On or about December 28, 2018, the City claimed, in error, that it had yet
`
`to receive a site plan that complied with the Zoning Code and that such a site plan was
`
`required for Planning Commission to consider BayMark’s Applications.
`
`63. The City and its Planning Commission also claimed that BayMark’s
`
`responses to the City’s litany of questions were “incomplete,” such that the Planning
`
`Commission could not act upon BayMark’s Applications. The Planning Commission did
`
`not and has not acted upon BayMark’s Applications.
`
`64. Yet, the City and its Planning Commission have had more than sufficient
`
`information to act upon the pending Applications since December 28, 2018. The Planning
`
`Commission has instead continuously refused to act upon or hear the Applications in
`
`contravention to the City’s established procedures.
`
`G. BayMark Amends Its Lease and Supplements the Applications.
`
`65. On or about June 5, 2020, BayMark and MKB entered into a First
`
`Amendment to Lease amending BayMark’s Lease. The amendment limits BayMark’s
`
`use of the building on the Property to 4,800 square feet.
`
`66. On or about August 14, 2020, BayMark provided the City with its First
`
`
`5 A “clinic” must provide 1 parking space per 200 sq.ft. of the clinic’s gross floor area. Zoning
`Code § 1187.06.
`
`
`
`16
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 17 of 29. PageID #: 17
`
`
`
`Amendment to Lease to supplement its pending Applications. A true and accurate copy
`
`of the August 14, 2020 letter is attached as Exhibit G.
`
`67. As a result of the amended lease, regardless of whether BayMark’s use is
`
`characterized as a “medical office” or “clinic,” the maximum number of parking spaces
`
`required by the Zoning Code for BayMark’s use of the Property is 24 spaces. See Zoning
`
`Code §1187.06. The Site Plan Application provides 24 spaces. (Ex. G at 9.) BayMark
`
`requested to have its Applications as supplemented by the First Amendment to Lease, be
`
`approved at the September 8, 2020 Commission meeting.
`
`68. The Planning Commission cancelled its September 8 and October 5, 2020
`
`Commission meetings.
`
`69.
`
`In a letter dated October 1, 2020, the City informed BayMark that “[a]t this
`
`time, there is a moratorium on planning activity in the region in question. The City will
`
`notify you when the moratorium is lifted.”
`
`70. On February 18, 2020, the City passed a moratorium on “the acceptance and
`
`approval by the City and City Planning Commission of new applications for
`
`development authorization and permits . . . .” for certain properties in the City. A true
`
`and accurate copy of Ordinance No. 22-2020, adopting the moratorium, is attached hereto
`
`as Exhibit H. On August 3, 2020, the City extended the moratorium for six additional
`
`months. A true and accurate copy of Ordinance No. 105-2020, adopting the moratorium,
`
`is attached hereto as Exhibit I (together, Ordinance Nos. 22-2020 and 105-2020 are the
`
`“Moratoria”).
`
`71.
`
`Importantly, neither moratorium was retroactive. There is not any language
`
`in the Moratoria that applies a moratorium to the consideration of applications that were
`
`
`
`17
`
`
`
`Case: 1:20-cv-02754-PAG Doc #: 1 Filed: 12/11/20 18 of 29. PageID #: 18
`
`
`
`previously pending before Planning Commission or concerning uses of property that were
`
`already vested by virtue of an applicant’s prior filing of a zoning application.
`
`72. BayMark’s Applications remained pending before the Commission prior to
`
`passage of the Moratoria. By their plain terms, neither Moratoria apply to Baymark’s
`
`pending Applications. Moreover, the Property has been vacant for years, to the extent the
`
`City refuses to accept any application from BayMark changing the Property’s use from
`
`its existing vacant use to any other use, deprives BayMark of all economic use of the
`
`Property of its rights under the Lease.
`
`H. Despite the Moratoria, the Planning Commission Continues to Act Upon Other
`Applications and Seeks to Rezone BayMark’s Property.
`
`73. The Planning Commission met on November 2, 2020 and considered an
`
`application for approval of a self-storage business to be located at 7011 West 130th Street
`
`in the City, along with other matters.
`
`74. The Planning Commission met on December 7, 2020 and considered
`
`approval of an application for a new development at 5889 Stumph Road. The Planning
`
`Commission also considered a separate rezoning recommendation that, if enacted, will
`
`rezone the Property to place additional restrictions on the future use, deve